series-a
Stage
1
Investors
About
Pulmagen Therapeutics is a biotechnology company focused on developing precision medicines for lung diseases, specializing in creating targeted therapies for respiratory conditions.
Explore Pulmagen Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.